Biological response modifiers and their promise in clinical medicine.
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000494:pharmacology; D007376:Interleukin-2 / Q000494:pharmacology; D008233:Lymphotoxin-alpha / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy; D013935:Thymic Factor, Circulating / Q000627:therapeutic use; D013947:Thymosin / Q000627:therapeutic use; D013951:Thymus Hormones / Q000494:pharmacology / Q000627:therapeutic use*; D014165:Transfer Factor / Q000627:therapeutic use*
D006131:Growth Inhibitors; D007375:Interleukin-1; D007376:Interleukin-2; D008233:Lymphotoxin-alpha; D013951:Thymus Hormones; D014165:Transfer Factor; D013947:Thymosin; D007372:Interferons; D013935:Thymic Factor, Circulating